Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan
- 27 July 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (32) , 3576-3583
- https://doi.org/10.1038/sj.onc.1203696
Abstract
By immunoscreening with an antibody raised against a plasma membrane protein, we have cloned a growth suppressor gene, Gros1 and assigned it to short arm of human chromosome 1. Two alternatively spliced forms of the gene encoding 84- and 41-kDa (carboxy-terminus truncated) proteins were cloned. The two transcripts, 4.4 and 2.7 kb, were expressed weakly in most of the human tissues, with a high expression of the smaller transcript in placenta, ovary and testis. Normal human fibroblasts in culture showed two transcripts, with a higher level of expression of the 4.4 kb transcript. Transformed cells on the other hand showed predominant expression of the 2.7 kb transcript. Two Gros1 transcripts were also detected in most of the mouse tissues. Stable transfection of the mouse cDNA encoding the 85-kDa protein into NIH3T3 cells resulted in their slow growth and reduced colony-forming efficiency. Stable clones expressing antisense RNA on the other hand exhibited higher colony forming efficiency. While our data implied that Gros1 is a novel growth suppressor gene on human chromosome 1, an independent study has recently characterized its rat-homolog as a leucine proline-enriched novel basement membrane-associated proteoglycan leprecan. We describe here cloning, expression and biological activity analysis implying that this novel proteoglycan is a potential growth suppressor on chromosome 1p31, frequently altered in many malignancies.Keywords
This publication has 32 references indexed in Scilit:
- Age-related Changes in the Proteoglycans of Human SkinArchives of Biochemistry and Biophysics, 2000
- Syndecan-1 expression has prognostic significance in head and neck carcinomaBritish Journal of Cancer, 1999
- Syndecan-1 (CD 138) in Myeloma and Lymphoid Malignancies: A Multifunctional Regulator of Cell Behavior Within the Tumor MicroenvironmentLeukemia & Lymphoma, 1999
- Intratumor distribution of 1p deletions in human colorectal adenocarcinoma is Commonly homogeneousCancer, 1998
- Leucine-rich repeat glycoproteins of the extracellular matrixMatrix Biology, 1998
- Allelic imbalance and cytogenetic deletion of 1p in colorectal adenomas: A target region identified between DIS199 and DIS234Genes, Chromosomes and Cancer, 1998
- Chromosome 1p aberrations are frequent in human primary hepatocellular carcinomaCancer Genetics and Cytogenetics, 1996
- Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastomaMedical and Pediatric Oncology, 1995
- High-resolution cytogenetic mapping of the short arm of chromosome 1 with newly isolated 411 cosmid markers by fluorescence in situ hybridization: the precise order of 18 markers on 1p36.1 on prophase chromosomes and “stretched” DNAsGenomics, 1995
- Chromosome I alterations in breast cancer: Allelic loss on Ip and Iq Is related to lymphogenic metastases and poor prognosisGenes, Chromosomes and Cancer, 1992